Navigation Links
Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
Date:2/8/2008

Huber, Jr., M.D., and Hans Rekers, M.D., will report to Robert J. Spiegel, M.D., chief medical officer and senior vice president. Huber is appointed vice president, Global Pharmacovigilance, and deputy chief medical officer. In this role, he will continue his current responsibilities and additionally will serve on Schering-Plough's Safety Review Board. He will also interact on product-related issues with health authorities and professional societies, manage medical aspects of litigation issues and work with medical directors from country operations on risk management and product-specific issues.

Huber has served as vice president, Global Pharmacovigilance, since joining Schering-Plough in July of 2006. He has played a key role in the development of a globally-aligned organization for Global Pharmacovigilance as part of Schering-Plough's Global Clinical Harmonization program and on the design and rollout of a rigorous computerized system for the collection, tracking and reporting of drug safety information. Huber received an M.D. degree from Baylor College of Medicine and a Bachelor of Science degree from Texas Lutheran College.

Hans Rekers, M.D., is appointed deputy chief medical officer for Europe. In this role, Rekers will continue his current responsibilities and additionally will serve on Schering-Plough's Safety Review Board and on the company's PReP (preparedness response) team. He will also interact on product- related issues with worldwide health authorities and professional societies, manage medical aspects of litigation issues and work with medical directors from country operations on risk management and product-specific issues.

Rekers has been with Organon International for the past 20 years serving in a range of positions of increasing responsibility, most recently as vice president, Medical Affairs. In this role, he has global oversight for the gynecological product portfolio. Rekers holds an M.D. from the University of Amsterdam. <
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
2. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
3. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
4. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
5. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Completes Acquisition of Organon BioSciences
8. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
9. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
10. Schering-Plough Announces Pricing of Senior Notes Offering
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or ... next steps for its Oral Amphotericin B program.  ... in vitro work involving samples from ... plans to complete pre clinical studies and regulatory ... 1A clinical trial, utilizing approximately $700,000 of funding ...
(Date:10/22/2014)... , Oct. 22, 2014 Research and ... Electronics Market by Material, by Application, Geography - Global ... their offering. Organic electronics, also called ... of material science which deals with small conductive molecules ... because small molecules and polymers are carbon based, made ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... Nov. 27 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, ... been granted,U.S. Patent 7,300,650 entitled "Reovirus for the ... the reovirus to treat cancers that,have inactivated PKR, ... Ras or,by other factors. PKR is a host ...
... their eyes need to capture all the light available. To ... surface of their eyes which allow almost no light to ... scientists at MicroBridge, a project at Cardiff Universitys Manufacturing Engineering ... lens for use in a low light environment. , The ...
... Mass., Nov. 26 Cambridge Research &,Instrumentation, Inc. ... systems in North America. The Maestro 2 received ... Molecular Imaging/Academy of Molecular,Imaging joint conference for in ... Imaging Workshop as well. Maestro 2, the fully,automated ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent 2CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems 2
(Date:10/19/2014)... the last 30 years contributed only marginally to ... time, according to a new study published in ... access is fundamental to development: it brings improvements ... and health," says IIASA researcher Shonali Pachauri, who ... is widely agreed to be an important goal ...
(Date:10/17/2014)... German . ... in order to reproduce? And why are there two sexes ... latest issue of the research journal Molecular Human Reproduction ... Ramm from Bielefeld University Bielefeld has compiled this special issue ... a female to copulate with several males in quick succession ...
(Date:10/16/2014)... new synthesis of recent research findings to inform their ... two states. , The Ecology and Management of ... Synthesis of the Relevant Biophysical Science and Implications for ... the U.S. Forest Service,s Pacific Northwest Research Station, is ... a synthesis of the large body of scientific information ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2
... that farmed Atlantic salmon escapees constitute to wild ... about farmed salmon yet heritable changes that have ... are largely unknown. , In new research published ... scientific evidence that farmed salmon have evolved genetically ...
... and heart inflammation takes a "back door" approach to ... human cells. Broadening knowledge of how viruses cause infection, ... has evolved to bypass the body's defenses. , "This ... cells," said Jeffrey M. Bergelson, M.D., a pediatric infectious ...
... wrong, researchers at the University of California, San Diego ... in a number of troublesome diseases are actually related. ... by disguising themselves, then hijacking their hosts. , Jack ... of Pharmacology and Cellular and Molecular Medicine at the ...
Cached Biology News:Research details how a virus hijacks cell signals to cause infection 2UCSD team unmasks family of immune system invaders 2UCSD team unmasks family of immune system invaders 3
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Mouse monoclonal [H4B4] to LAMP2 - Lysosome Marker (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 3920 SwissProtID: P13473...
... NIS-Elements revolutionizes imaging software for the ... to microscopes, cameras, components and peripherals ... achiving tools. Its intuitive interface simplifies ... times while providing powerful features such ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
Biology Products: